Raymond James Trust’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $982K | Buy |
3,271
+389
| +13% | +$117K | 0.02% | 505 |
|
|
2024
Q2 | $949K | Buy |
2,882
+137
| +5% | +$45.1K | 0.02% | 486 |
|
|
2024
Q1 | $1.09M | Sell |
2,745
-124
| -4% | -$49.1K | 0.03% | 450 |
|
|
2023
Q4 | $1.01M | Buy |
2,869
+45
| +2% | +$15.8K | 0.03% | 454 |
|
|
2023
Q3 | $1.06M | Sell |
2,824
-55
| -2% | -$20.6K | 0.03% | 409 |
|
|
2023
Q2 | $1.1M | Buy |
2,879
+111
| +4% | +$42.5K | 0.03% | 408 |
|
|
2023
Q1 | $959K | Buy |
2,768
+508
| +22% | +$176K | 0.03% | 420 |
|
|
2022
Q4 | $532K | Sell |
2,260
-580
| -20% | -$137K | 0.02% | 575 |
|
|
2022
Q3 | $699K | Buy |
2,840
+86
| +3% | +$21.2K | 0.03% | 465 |
|
|
2022
Q2 | $833K | Sell |
2,754
-251
| -8% | -$75.9K | 0.03% | 423 |
|
|
2022
Q1 | $1.23M | Buy |
3,005
+90
| +3% | +$37K | 0.04% | 362 |
|
|
2021
Q4 | $1.37M | Buy |
2,915
+53
| +2% | +$24.9K | 0.04% | 349 |
|
|
2021
Q3 | $1.22M | Buy |
2,862
+149
| +5% | +$63.3K | 0.04% | 348 |
|
|
2021
Q2 | $974K | Sell |
2,713
-339
| -11% | -$122K | 0.03% | 410 |
|
|
2021
Q1 | $860K | Buy |
3,052
+1,954
| +178% | +$551K | 0.03% | 412 |
|
|
2020
Q4 | $311K | Sell |
1,098
-120
| -10% | -$34K | 0.01% | 760 |
|
|
2020
Q3 | $335K | Buy |
1,218
+337
| +38% | +$92.7K | 0.01% | 651 |
|
|
2020
Q2 | $200K | Buy |
+881
| New | +$200K | 0.01% | 847 |
|